Instil Bio Inc TIL

Healthcare Biotechnology

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.

NDAQ:TIL - Post by User

Instil Bio Inc

Bullboard Posts

Comment by Giverbulletson Aug 18, 2011 1:23am

346 Views

Post# 18954774

RE: RE: RE: Soil Sampling @ Livingston District

150 K ! Nice. I guess I'm a little late to the trough but I think there should be enough to fatten up on. It's always better to buy on the uptrend rather than try to catch those falling knives anyways.

So guys,what's the deal with the 43-101's? Can we figure out what they are by the drill samples? What kind of numbers should we expect to see? Scotty you were crunching some numbers the other week, but said you made a mistake, do you mind clarifying?

Thx

Giver

Bullboard Posts

This battery metals stock is on a path to the global stage